MedTrace Logo

Artemether-Lumefantrine Effectiveness in Guinea-Bissau

NCT01157689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-05-19

No results posted yet for this study

Summary

The routine treatment of children with antimalarials will be monitored. Children with a positive malaria film and/or a positive rapid diagnostic test (RDT) will be included in a follow-up study. The genetic basis of the parasites for developing resistance will be examined. In case of reappearance of parasites the child will be re-treated following the guidelines of the national malaria programme.

Conditions

Sponsors & Collaborators

  • Bandim Health Project

    lead OTHER

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-12-31
Completion
2016-06-30

Countries

  • Guinea-Bissau

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01157689 on ClinicalTrials.gov